Effects of oestrogen on cardiovascular events in postmenopausal women

被引：0
|
作者：
Herrington, DM [1 ]
机构：
[1] Wake Forest Univ, Sch Med, Dept Internal Med Cardiol, Winston Salem, NC 27157 USA
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2001年 / 3卷 / 0M期
关键词：
cardiovascular disease; hormone replacement therapy; oestrogen. primary prevention; secondary prevention;
D O I：
10.1016/S1520-765X(01)90076-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A number of randomized clinical trials have investigated the role of hormone replacement therapy (HRT) in primary and secondary prevention of clinical and anatomical manifestations of atherosclerosis. There is mounting evidence that HRT does not slow the progression of clinical or anatomical manifestations of atherosclerosis in women with established disease. Indeed, there appears to be a pattern of increased risk among new users of HRT. In contrast, there are encouraging new data that suggest that HRT may be more effective in women who have not yet developed clinical manifestations of coronary disease. (C) 2001 The European Society of Cardiology.
引用
收藏
页码：M7 / M11
页数：5
相关论文
共 50 条
  • [31] Osteoporosis Prevention and Treatment: The Risk of Comorbid Cardiovascular Events in Postmenopausal Women
    Gilbert, Zachary A.
    Muller, Avia
    Leibowitz, Jillian A.
    Kesselman, Marc M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
  • [32] Effects of calcium intake on the cardiovascular system in postmenopausal women
    Challoumas, D.
    Cobbold, C.
    Dimitrakakis, G.
    ATHEROSCLEROSIS, 2013, 231 (01) : 1 - 7
  • [33] THE USE OF ESTROGENS IN POSTMENOPAUSAL WOMEN - THE IMPORTANCE OF CARDIOVASCULAR EFFECTS
    HILLNER, BE
    HOLLENBERG, JP
    PAUKER, SG
    CLINICAL RESEARCH, 1984, 32 (05): : A922 - A922
  • [34] Oestrogen therapy for prevention of reinfarction in postmenopausal women - ESPRIT (Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial)
    Lyakishev, AA
    KARDIOLOGIYA, 2003, 43 (05) : 75 - 75
  • [35] Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT)
    Sourander, L
    Rajala, T
    Räihä, I
    Mäkinen, J
    Erkkola, R
    Helenius, H
    LANCET, 1998, 352 (9145): : 1965 - 1969
  • [36] The influence of oestrogen replacement on faecal incontinence in postmenopausal women
    Donnelly, V
    OConnell, PR
    OHerlihy, C
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 (03): : 311 - 315
  • [37] The effects of transdermal and oral oestrogen replacement therapy on colorectal cancer risk in postmenopausal women
    Csizmadi, I
    Collet, JP
    Benedetti, A
    Boivin, JF
    Hanley, JA
    BRITISH JOURNAL OF CANCER, 2004, 90 (01) : 76 - 81
  • [38] The effects of transdermal and oral oestrogen replacement therapy on colorectal cancer risk in postmenopausal women
    I Csizmadi
    J-P Collet
    A Benedetti
    J-F Boivin
    J A Hanley
    British Journal of Cancer, 2004, 90 : 76 - 81
  • [39] Anabolic effects of high-dose oestrogen therapy in postmenopausal women: A histomorphometric study
    Vedi, S
    Ballard, P
    Bord, S
    Purdie, DW
    Compston, JE
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (09) : O7 - O7
  • [40] Raloxifene, conjugated oestrogen and endothelial function in postmenopausal women
    Duschek, EJJ
    Stehouwer, CDA
    De Valk-De Roo, GW
    Schalkwijk, CG
    Lambert, J
    Netelenbos, C
    JOURNAL OF INTERNAL MEDICINE, 2003, 254 (01) : 85 - 94
12345